FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to oncology, and can be used in treating mesothelioma or follicular lymphoma ensured by an oral pharmaceutical composition containing suberoylanilide-hydroxamine acid (SAHA) in effective amount. Besides, it is offered to use these compositions in a set.
EFFECT: inventions ensure effective treatment of the specified tumours ensured by suppressed proliferation of tumour cells.
14 cl, 5 tbl, 6 ex, 17 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INDUCTION OF TERMINAL DIFFERENTIATION | 2003 |
|
RU2320331C2 |
| METHOD OF FINAL DIFFERENTIATION INDUCTION | 2010 |
|
RU2530648C2 |
| METHOD OF INDUCING TERMINAL DIFFERENTIATION | 2003 |
|
RU2394022C2 |
| COMPOSITIONS OF SUBEROYLANILIDE-HYDROXAMIC ACID AND METHODS OF OBTAINING THEM | 2006 |
|
RU2354362C2 |
| METHODS OF TREATING CANCER USING APILIMOD | 2016 |
|
RU2738934C2 |
| VITAMIN C AND CHROME-FREE VITAMIN K AND THEREOF-CONTAINING COMPOSITIONS FOR TREATMENT OF NFKB-MEDIATED CONDITION OR DISEASE | 2011 |
|
RU2575833C2 |
| 2,4-DISULFONYL-α-PHENYL-TERT-BUTYLNITRON, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FORM OF FREE ACID OR SALT FORM THEREOF, PHARMACEUTICAL COMPOSITIONS AND METHODS OF MEDICAL TREATMENT | 1994 |
|
RU2159231C2 |
| COMBINATIONS CONTAINING EPOTHILONES AND ANTIMETABOLITES | 2003 |
|
RU2346686C2 |
| METHOD OF TREATMENT BY APPLICATION OF COMBINED THERAPY | 2010 |
|
RU2543348C2 |
| D-TAGATOSE COMPOSITIONS AND METHODS OF PREVENTING AND TREATING ATHEROSCLEROSIS, METABOLIC SYNDROME AND SYMPTOMS THEREOF | 2009 |
|
RU2484827C2 |
